ValorQ4, 24Q1, 25Q2, 25TTMSelling/general/admin expenses265.13 M259.19 M278.4 M1.05 BResearch & development86.44 M87.32 M90.97 M348.68 MOperating income454.54 M446.54 M491.66 M1.82 BNon-Operating Income, Total3.51 M256 K4.49 M-317 KInterest expense, net of interest capitalized————Non-Operating Income, excl. Interest Expenses4.49 M4.09 M9.77 M13.84 MUnusual income/expense-979 K-3.84 M-5.28 M-14.15 MPretax income458.05 M446.79 M496.15 M1.82 BEquity in earnings1.27 M1.49 M1.51 M4.61 MTaxes78.35 M98.26 M103.56 M332.81 MNon-controlling/minority interest————After tax other income/expense————Net income before discontinued operations379.7 M348.54 M392.59 M1.49 BDiscontinued operations————Net income379.7 M348.54 M392.59 M1.49 BDilution adjustment————Preferred dividends————Diluted net income available to common stockholders379.7 M348.54 M392.59 M1.49 BBasic earnings per share (Basic EPS)2.592.382.6910.15Diluted earnings per share (Diluted EPS)2.582.372.6810.11Average basic shares outstanding146.72 M146.18 M145.84 M585.46 MDiluted shares outstanding147.34 M146.9 M146.37 M587.83 MEBITDA518.17 M494.24 M541.54 M2.02 BEBIT454.54 M446.54 M491.66 M1.82 BCost of revenue527.93 M514.76 M544.08 M2.11 BOther cost of goods sold518.56 M506.94 M536.28 M2.08 BDepreciation & amortization (cash flow)63.63 M47.7 M49.88 M204.89 M
ResMed Inc
ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024.